Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11356-021-15183-9 http://scihub22266oqcxt.onion/10.1007/s11356-021-15183-9 34212320!8248285!34212320     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Environ+Sci+Pollut+Res+Int 2022 ; 29 (57): 85569-85573 Nephropedia Template TP {{tp|p=34212320|t=2022. Increased Levels of serum Pentraxin 3 in Critical Coronavirus Disease-2019 Patients |pdf=|usr=}}{{34212320}} gab.com Text Increased Levels of serum Pentraxin 3 in Critical Coronavirus Disease-2019 Patients JO: Environ Sci Pollut Res Int http://www.kidney.de/pget.php?&tw=1&pmid=34212320 #FOAvip Pentraxin 3 (PTX3) and ficolin are the plasma phase of pattern recognition receptors (PRRs) and can activate complement through classical and lectin pathways, respectively, which may contribute to disease severity. This study aimed to investigate the association between PTX3 and ficolin with disease severity in patients with coronavirus disease-2019 (COVID-19). Seventy-three COVID-19 patients and 25 healthy controls were enrolled in this study. The participants were divided into three groups as follows: 14 patients as the intensive care unit (ICU) group, 59 patients as the non-ICU group, and 25 subjects as the healthy control group. The serum levels of PTX3 and ficolin were measured by enzyme-linked immunosorbent assay (ELISA) kits. Patients in ICU and non-ICU groups had significantly higher levels of PTX3 compared to the healthy control group (p = 0.0002 and p = 0.0072, respectively). Patients in the ICU group also had an increased amount of PTX3 (1957 +/- 1769 pg/ml) compared to non-ICU patients (1220 +/- 1784 pg/ml). However, this difference was not significant. On the other hand, serum levels of ficolin were not different among the three groups. PTX3, as an acute phase protein, may contribute to disease severity. Its probable inflammatory role could result from the high activation of the complement system. On the other hand, it could be suggested that ficolin has no crucial role in the disease severity of COVID-19 patients. Twit Text FOAVip Increased Levels of serum Pentraxin 3 in Critical Coronavirus Disease-2019 Patients ????Environ Sci Pollut Res Int http://www.kidney.de/pget.php?&tw=1&pmid=34212320 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34212320 #FOAvip English Wikipedia <ref>{{Cite pmid|34212320}}</ref> Increased Levels of serum Pentraxin 3 in Critical Coronavirus Disease-2019 Patients #MMPMID34212320 Moulana Z; Bagherzadeh M; Mirzakhani M; Rostami A; Mohammadnia-Afrouzi M; Shahbazi M Environ Sci Pollut Res Int 2022[Dec]; 29 (57): 85569-85573 PMID34212320show ga Pentraxin 3 (PTX3) and ficolin are the plasma phase of pattern recognition receptors (PRRs) and can activate complement through classical and lectin pathways, respectively, which may contribute to disease severity. This study aimed to investigate the association between PTX3 and ficolin with disease severity in patients with coronavirus disease-2019 (COVID-19). Seventy-three COVID-19 patients and 25 healthy controls were enrolled in this study. The participants were divided into three groups as follows: 14 patients as the intensive care unit (ICU) group, 59 patients as the non-ICU group, and 25 subjects as the healthy control group. The serum levels of PTX3 and ficolin were measured by enzyme-linked immunosorbent assay (ELISA) kits. Patients in ICU and non-ICU groups had significantly higher levels of PTX3 compared to the healthy control group (p = 0.0002 and p = 0.0072, respectively). Patients in the ICU group also had an increased amount of PTX3 (1957 +/- 1769 pg/ml) compared to non-ICU patients (1220 +/- 1784 pg/ml). However, this difference was not significant. On the other hand, serum levels of ficolin were not different among the three groups. PTX3, as an acute phase protein, may contribute to disease severity. Its probable inflammatory role could result from the high activation of the complement system. On the other hand, it could be suggested that ficolin has no crucial role in the disease severity of COVID-19 patients. |*COVID-19/blood/genetics/metabolism[MESH] |*Coronavirus/metabolism[MESH] |C-Reactive Protein/analysis[MESH] |Ficolins[MESH] |Humans[MESH]Increased Levels of serum Pentraxin 3 in Critical Coronavirus Disease(epmc).pdf DeepDyve Pubget Overpricing